Writing exercises for young cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study explores the feasibility and acceptability of a writing-based narrative medicine intervention for adolescents and young adults with cancer. Participants aged 15-25 will engage in writing about their cancer experiences, guided by an expert writer. They will have the option to meet with the writer for support over a two-month period and will share their thoughts on the experience through informal interviews conducted at various intervals. The study aims to assess whether creative writing can enhance the well-being of young cancer patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 15-25
* Currently receiving cancer-directed therapy
* Active patient at St. Jude Children's Research Hospital
* Parent of a ChronCan participant who has passed away

Exclusion Criteria:

* Does not meet the inclusion criteria
* If the parents have not responded or not interviewed till July 31, 2027.

Where it's running

• St. Jude Children's Research Hospital
  Memphis, Tennessee, United States Recruiting

Study contacts

• Principal investigator: Erica Kaye, MD — St. Jude Children's Research Hospital
• Study coordinator: Erica Kaye, MD
• Email: referralinfo@stjude.org
• Phone: 888-226-4343

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One-Page Truth-Telling Aid to Guide Cancer Discussions

  A one-page tool is tested to help doctors quickly understand a cancer patient’s information preferences before a consultation.

  Recruiting Chang Gung University · Taoyuan · NCT07730164

• Testing AI translation vs. professional translation for knowledge resources for parents

  We’re testing whether an AI translation of parent-focused health resources works as well as professional translation for Mandarin, Punjabi, Tagalog, and Urdu-speaking families in Canada.

  Recruiting University of Alberta · Edmonton, Alberta · NCT07666399

• Diosmin/Hesperidin to Protect Kidneys in Platinum Chemotherapy

  This study tests whether taking diosmin and hesperidin helps protect the kidneys of cancer patients who are receiving platinum-based chemotherapy.

  Recruiting Phase 4 Beni-Suef University · Banī Suwayf · NCT07598214

• Tibetree topical herbal plasters for people using opioids for cancer pain

  This trial will try Tibetree topical herbal plasters together with prescribed opioids to see if they reduce localized cancer-related pain for adults who are currently taking short-term oral opioids.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07447856

• CONNECT: Extra Post-discharge Phone Support to Reinforce After-Visit Summaries

  This pilot tests whether adding a detailed, language-concordant post-discharge phone call helps patients who prefer Spanish, Haitian Creole, Portuguese, Cape Verdean, or Vietnamese understand their after-visit summary and avoid problems after leaving the hospital.

  Recruiting Boston Medical Center · Boston, Massachusetts · NCT07032818

• Comparing two methods of pain control after kidney surgery in cancer patients

  This study is testing two different ways to control pain after kidney surgery in cancer patients to see which method works better.

  Recruiting National Cancer Institute, Egypt · Cairo · NCT06889987

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.